| Seminar: | (352) Structural Investigation of the Voltage-gated Calcium Channel Cav1.1 |
| Speaker: | Dr. Jianping Wu, Princeton University, USA |
| Time: | 2019-04-18 15:00 to 2019-04-18 16:00 |
| Venue: | Meeting room (406), Building 24 |
| Organizer: |
SPST Abstract: Voltage-gated calcium (Cav) channels are important membrane proteins that mediate calcium influx upon action potential. They are involved in a variety of physiological processes, such as muscle contraction, hormone secretion, synaptic transmission and gene expression. Malfunction of Cav channels are associated with many neurological and cardiovascular diseases. Therefore, Cav channels are very important drug targets. In fact, several clinical drugs targeted on Cav1 channels have already been widely used for treatment of hypertension. Cav1.1 was the first identified among the 10 Cav channels in mammals and it plays an essential role during excitation-contraction (E-C) coupling duringskeletal muscle contraction. In the past few years, we were focusing on the structural investigation on Cav1.1. We sought an innovative strategy to purify the large protein complex form endogenous tissue. Using single particle cryo-EM, we solved the structure of Cav1.1, which was the first high resolution structure of a eukaryotic Cav channel. The structure helped explaining the subunits assembly, ion selectivity, electro-mechanical coupling of Cav channels. By combining the study on another ion channel RyR1, we also proposed a working model for EC-coupling in skeletal muscle. Recently, we also solved the structures of Cav1.1 in complex with multiple clinical drugs. These structures elucidate the structural basis for specific drug recognition and will provide important framework for future drug developments. |
| Seminar: | (352) Structural Investigation of the Voltage-gated Calcium Channel Cav1.1 |
| Speaker: | Dr. Jianping Wu, Princeton University, USA |
| Time: | 2019-04-18 15:00 to 2019-04-18 16:00 |
| Venue: | Meeting room (406), Building 24 |
| Organizer: |
SPST Abstract: Voltage-gated calcium (Cav) channels are important membrane proteins that mediate calcium influx upon action potential. They are involved in a variety of physiological processes, such as muscle contraction, hormone secretion, synaptic transmission and gene expression. Malfunction of Cav channels are associated with many neurological and cardiovascular diseases. Therefore, Cav channels are very important drug targets. In fact, several clinical drugs targeted on Cav1 channels have already been widely used for treatment of hypertension. Cav1.1 was the first identified among the 10 Cav channels in mammals and it plays an essential role during excitation-contraction (E-C) coupling duringskeletal muscle contraction. In the past few years, we were focusing on the structural investigation on Cav1.1. We sought an innovative strategy to purify the large protein complex form endogenous tissue. Using single particle cryo-EM, we solved the structure of Cav1.1, which was the first high resolution structure of a eukaryotic Cav channel. The structure helped explaining the subunits assembly, ion selectivity, electro-mechanical coupling of Cav channels. By combining the study on another ion channel RyR1, we also proposed a working model for EC-coupling in skeletal muscle. Recently, we also solved the structures of Cav1.1 in complex with multiple clinical drugs. These structures elucidate the structural basis for specific drug recognition and will provide important framework for future drug developments. |